» Articles » PMID: 35262905

Blocking of Caveolin-1 Attenuates Morphine-Induced Inflammation, Hyperalgesia, and Analgesic Tolerance Via Inhibiting NLRP3 Inflammasome and ERK/c-JUN Pathway

Overview
Journal J Mol Neurosci
Date 2022 Mar 9
PMID 35262905
Authors
Affiliations
Soon will be listed here.
Abstract

Morphine is generally used to treat chronic pain in clinic. But long-term use of morphine can inevitably induce analgesic tolerance and hyperalgesia. Caveolin-1 is reported to affect morphine-mediated signaling transduction. However, the action mechanism of morphine-induced analgesic tolerance is still unknown. In this study, morphine-induced analgesic tolerance model was established in Sprague-Dawley rats. The effects of Caveolin-1 blocking on neuroinflammation and ERK/c-JUN pathway were then explored. Morphine can remarkably elevate the expression level of Caveolin-1. Based on paw withdrawal latency behavior test, we found that Caveolin-1 blocking can effectively attenuate morphine-induced analgesic tolerance and neuroinflammation. Activation of ERK/c-JUN significantly reversed the above influences caused by Caveolin-1 blocking. Taken together, blocking of Caveolin-1 can attenuate morphine-induced inflammation and analgesic tolerance through inhibiting NLRP3 inflammasome and ERK/c-JUN pathway.

Citing Articles

Caveolin-1 regulates inflammatory mediators in retinal endothelial cells.

Jiang Y, Liu L, Al-Shabrawey M, Steinle J Mol Vis. 2025; 30:298-303.

PMID: 39959177 PMC: 11829789.


DHCR24 Insufficiency Promotes Vascular Endothelial Cell Senescence and Endothelial Dysfunction via Inhibition of Caveolin-1/ERK Signaling.

Li H, Yang Z, Liang W, Nie H, Guan Y, Yang N J Gerontol A Biol Sci Med Sci. 2024; 79(4).

PMID: 38407305 PMC: 10949436. DOI: 10.1093/gerona/glae059.


Zingerone Alleviates Morphine Tolerance and Dependence in Mice by Reducing Oxidative Stress-Mediated NLRP3 Inflammasome Activation.

Molavinia S, Nikravesh M, Pashmforoosh M, Rajabi Vardanjani H, Khodayar M Neurochem Res. 2023; 49(2):415-426.

PMID: 37864024 DOI: 10.1007/s11064-023-04043-2.

References
1.
Almela P, Garcia-Nogales P, Romero A, Milanes M, Laorden M, Puig M . Effects of chronic inflammation and morphine tolerance on the expression of phospho-ERK 1/2 and phospho-P38 in the injured tissue. Naunyn Schmiedebergs Arch Pharmacol. 2008; 379(3):315-23. DOI: 10.1007/s00210-008-0356-x. View

2.
Cai Y, Kong H, Pan Y, Jiang L, Pan X, Hu L . Procyanidins alleviates morphine tolerance by inhibiting activation of NLRP3 inflammasome in microglia. J Neuroinflammation. 2016; 13(1):53. PMC: 4774188. DOI: 10.1186/s12974-016-0520-z. View

3.
Chakrabarti S, Chang A, Liu N, Gintzler A . Chronic opioid treatment augments caveolin-1 scaffolding: relevance to stimulatory μ-opioid receptor adenylyl cyclase signaling. J Neurochem. 2016; 139(5):737-747. PMC: 5123915. DOI: 10.1111/jnc.13852. View

4.
Chen R, Yin C, Fang J, Liu B . The NLRP3 inflammasome: an emerging therapeutic target for chronic pain. J Neuroinflammation. 2021; 18(1):84. PMC: 8008529. DOI: 10.1186/s12974-021-02131-0. View

5.
de Freitas B, Pereira L, Santa-Cecilia F, Hosch N, Picolo G, Cury Y . Mitogen-Activated Protein Kinase Signaling Mediates Morphine Induced-Delayed Hyperalgesia. Front Neurosci. 2019; 13:1018. PMC: 6763729. DOI: 10.3389/fnins.2019.01018. View